Quality Over Quantity for Antibodies Makes the Difference in a Promising Malaria Vaccine (1 of 1) (IMAGE)

American Association for the Advancement of Science (AAAS)

Quality Over Quantity for Antibodies Makes the Difference in a Promising Malaria Vaccine (1 of 1)

Caption

Microscopic images of natural killer cells and malaria parasites (SPZ) either alone or alongside the MAB311 antibody. This material relates to a paper that appeared in the Jul. 22, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by T.J. Suscovich at Ragon Institute of MGH, Harvard, and MIT in Cambridge, MA; and colleagues was titled, "Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination."

Credit

[Credit: T.J. Suscovich <i>et al., Science Translational Medicine</i> (2020)]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.